The administration of NLRP3 inhibitor MCC950, 4 h after the induction of ascending UTI without a catheter, resulted in a 3-fold, statistically significant reduction in bladder CFUs at 24 hpi and a corresponding reduction in kidney CFUs that was statistically non-significant. This evidence concerns the gene NLRP3 and bacterial urinary tract infection.